General Update

Revenue Growth 20pctPat Growth 25pctResults View source PDF

METROPOLIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-5.0%1-day move

₹550.00

prior close

₹600.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-4.3-4.8-5.2-6.2-5.0-7.9-7.7-5.5-4.5-4.3-3.5-4.4+1.3—

Up moveDown movePending

AI summary

Metropolis Healthcare has filed revised consolidated financial results correcting an inadvertent error in the 'Profit attributable to owners of the Company' for the quarter ended March 31, 2025 (comparative period). The company states the correction has no impact on current FY2026 figures and is not material in nature. The filing includes audited standalone and consolidated results for FY2026 showing strong performance with consolidated revenue of Rs 16,458 crore (up 23.6% YoY) and consolidated PAT of Rs 1,900 crore (up 31.1% YoY for owners). The standalone PAT for FY2026 was Rs 1,575 crore, up 26.2% from Rs 1,248 crore in FY2025.

Likely market impact

The administrative correction to prior year comparative figures is minor and should not materially impact investor sentiment. The underlying FY2026 results demonstrate strong operational performance with consistent revenue and profit growth, which should be viewed positively by shareholders.